 |
인쇄하기
취소
|
LG Life Sciences signs drug export deal
LG Life Sciences, a local drug maker, said on January 12 that it has signed a contract with a China pharmaceutical company to export a newly developed substance for a drug to cure diabetes.
The deal with Beijing Double-Crane Pharmaceutical Co., Ltd. (DCPC) was in the scale of $4 million, according to LGLS officials.
LGLS will provide DCPC with the technology to produce gemigliptin (dipep...
The deal with Beijing Double-Crane Pharmaceutical Co., Ltd. (DCPC) was in the scale of $4 million, according to LGLS officials.
LGLS will provide DCPC with the technology to produce gemigliptin (dipep...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.